Terms: = Liver cancer AND CLIP1, ENSG00000130779, 6249, P30622, RSN, MGC131604, CYLN1, CLIP170, CLIP-170, CLIP AND Prognosis
117 results:
1. Advances in post-operative prognostic models for hepatocellular carcinoma.
He Z; She X; Liu Z; Gao X; Lu LU; Huang J; Lu C; Lin Y; Liang R; Ye J
J Zhejiang Univ Sci B; 2023 Mar; 24(3):191-206. PubMed ID: 36915996
[TBL] [Abstract] [Full Text] [Related]
2. prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment.
Chen CT; Feng YH; Yen CJ; Chen SC; Lin YT; Lu LC; Hsu CH; Cheng AL; Shao YY
Hepatol Int; 2022 Oct; 16(5):1199-1207. PubMed ID: 35986846
[TBL] [Abstract] [Full Text] [Related]
3. A Risk Model Developed Based on Necroptosis Predicts Overall Survival for Hepatocellular Carcinoma and Identification of Possible Therapeutic Drugs.
Li Z; Fang J; Chen S; Liu H; Zhou J; Huang J; Liu S; Peng Y
Front Immunol; 2022; 13():870264. PubMed ID: 35422802
[TBL] [Abstract] [Full Text] [Related]
4. Systematic review and meta-analysis of validated prognostic models for resected hepatocellular carcinoma patients.
Beumer BR; Buettner S; Galjart B; van Vugt JLA; de Man RA; IJzermans JNM; Koerkamp BG
Eur J Surg Oncol; 2022 Mar; 48(3):492-499. PubMed ID: 34602315
[TBL] [Abstract] [Full Text] [Related]
5. Port site metastases a year after initial laparoscopic cholecystectomy. Should the use of retrieval bags during laparoscopic cholecystectomy be the new gold standard?
Petryshyn N; Dražić T; Hogendorf P; Strzelczyk J; Strzałka A; Szwedziak K; Durczyński A
Pol Przegl Chir; 2021 May; 93(6):61-65. PubMed ID: 36169533
[TBL] [Abstract] [Full Text] [Related]
6. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1.
Du JX; Luo YH; Zhang SJ; Wang B; Chen C; Zhu GQ; Zhu P; Cai CZ; Wan JL; Cai JL; Chen SP; Dai Z; Zhu W
J Exp Clin Cancer Res; 2021 May; 40(1):171. PubMed ID: 33992102
[TBL] [Abstract] [Full Text] [Related]
7. Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.
Marasco G; Colecchia A; Bacchi Reggiani ML; Celsa C; Farinati F; Giannini EG; Benevento F; Rapaccini GL; Caturelli E; Di Marco M; Biasini E; Marra F; Morisco F; Foschi FG; Zoli M; Gasbarrini A; Baroni GS; Masotto A; Sacco R; Raimondo G; Azzaroli F; Mega A; Vidili G; Brunetto MR; Nardone G; Dajti E; Ravaioli F; Avanzato F; Festi D; Trevisani F;
Dig Liver Dis; 2021 Aug; 53(8):1011-1019. PubMed ID: 33353858
[TBL] [Abstract] [Full Text] [Related]
8. Gastrointestinal tract injuries after thermal ablative therapies for hepatocellular carcinoma: A case report and review of the literature.
Rogger TM; Michielan A; Sferrazza S; Pravadelli C; Moser L; Agugiaro F; Vettori G; Seligmann S; Merola E; Maida M; Ciarleglio FA; Brolese A; de Pretis G
World J Gastroenterol; 2020 Sep; 26(35):5375-5386. PubMed ID: 32994695
[TBL] [Abstract] [Full Text] [Related]
9. [Prediction model of mid-term fatality risk after radical resection in patients with hepatocellular carcinoma based on ALBI-grade].
Wang X; Zhang Z; Wu Z; Sun Y; Zhang Y; Gong M; Ji F
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(3):375-382. PubMed ID: 32762166
[TBL] [Abstract] [Full Text] [Related]
10. Machine learning-based development and validation of a scoring system for progression-free survival in liver cancer.
Liu X; Hou Y; Wang X; Yu L; Wang X; Jiang L; Yang Z
Hepatol Int; 2020 Jul; 14(4):567-576. PubMed ID: 32556865
[TBL] [Abstract] [Full Text] [Related]
11. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic role of collagen-III and matrix metalloproteinase-1 for early detection of hepatocellular carcinoma.
Attallah AM; Albannan MS; El-Deen MS; Farid K; Khedr FM; Attallah KA; Abdallah SO
Br J Biomed Sci; 2020 Apr; 77(2):58-63. PubMed ID: 31903873
[No Abstract] [Full Text] [Related]
13. Comprehensive analysis of biological networks and the eukaryotic initiation factor 4A-3 gene as pivotal in hepatocellular carcinoma.
Lin Y; Liang R; Mao Y; Ye J; Mai R; Gao X; Liu Z; Wainwright T; Li Q; Luo M; Ge L; Li Y; Zou D
J Cell Biochem; 2020 Oct; 121(10):4094-4107. PubMed ID: 31898336
[TBL] [Abstract] [Full Text] [Related]
14. Staging systems of hepatocellular carcinoma: A review.
Tellapuri S; Sutphin PD; Beg MS; Singal AG; Kalva SP
Indian J Gastroenterol; 2018 Nov; 37(6):481-491. PubMed ID: 30593649
[TBL] [Abstract] [Full Text] [Related]
15. A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection.
Cai BB; Shi KQ; Li P; Chen BC; Shi L; Johnson PJ; Lai P; Toyoda H; Zhou MT
Clin Chim Acta; 2018 Oct; 485():187-194. PubMed ID: 29908940
[TBL] [Abstract] [Full Text] [Related]
16. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
[TBL] [Abstract] [Full Text] [Related]
17. Pure laparoscopic radical resection for type IIIa hilar cholangiocarcinoma.
Zhang CW; Liu J; Hong DF; Wang ZF; Hu ZM; Huang DS; Shang MJ; Yao WF
Surg Endosc; 2018 Mar; 32(3):1581-1582. PubMed ID: 28779241
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis.
Li SH; Wang QX; Yang ZY; Jiang W; Li C; Sun P; Wei W; Shi M; Guo RP
World J Gastroenterol; 2017 May; 23(17):3122-3132. PubMed ID: 28533669
[TBL] [Abstract] [Full Text] [Related]
19. Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort.
Adhoute X; Pénaranda G; Raoul JL; Edeline J; Blanc JF; Pol B; Campanile M; Perrier H; Bayle O; Monnet O; Beaurain P; Muller C; Castellani P; Le Treut YP; Bronowicki JP; Bourlière M
World J Gastroenterol; 2017 Apr; 23(14):2545-2555. PubMed ID: 28465639
[TBL] [Abstract] [Full Text] [Related]
20. Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers.
Takeuchi S; Rohren EM; Abdel-Wahab R; Xiao L; Morris JS; Macapinlac HA; Hassan MM; Kaseb AO
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):969-978. PubMed ID: 27942837
[TBL] [Abstract] [Full Text] [Related]
[Next]
